Therefore, given the plethora of molecular mechanisms in which BLM is involved in the cells, it is likely that the different sensitivity to ML216 inhibitor shown by our panel of MM cell lines would depend not only on each cell line tolerance to DNA damage, but also to alterations in the other BLM-regulated processes. Here, BLM is linked to Miyoshi myopathy.